Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.

April 18, 2021

NSDHL promotes triple-negative breast cancer metastasis through the TGFβ signaling pathway and cholesterol biosynthesis.

Breast Cancer Research and Treatment
Mengting ChenWei Jin
April 18, 2021

DUSP16 promotes cancer chemoresistance through regulation of mitochondria-mediated cell death.

Nature Communications
Heng Boon LowYongliang Zhang
April 16, 2021

ANETT: PhAse II trial of NEoadjuvant TAK-228 plus Tamoxifen in patients with hormone receptor-positive breast cancer.

Breast Cancer Research and Treatment
Emre KocaJenny Chee Ning Chang
April 16, 2021

Prosigna test in breast cancer: real-life experience.

Breast Cancer Research and Treatment
D HequetR Rouzier
April 16, 2021
Review
Open Access

MicroRNAs as the critical regulators of Doxorubicin resistance in breast tumor cells.

Cancer Cell International
Amir Sadra ZangoueiMeysam Moghbeli
April 16, 2021

Discovering novel cancer bio-markers in acquired lapatinib resistance using Bayesian methods.

Briefings in Bioinformatics
A K M Azad, Salem A Alyami
April 16, 2021

Study of ER Stress and Apoptotic Proteins in the Heart and Tumor Exposed to Doxorubicin.

Biochimica Et Biophysica Acta. Molecular Cell Research
Ashim K BagchiPawan K Singal
April 16, 2021
Open Access

Repositioning metformin and propranolol for colorectal and triple negative breast cancers treatment.

Scientific Reports
L E AnselminoM Menacho Márquez
April 14, 2021
Preprint
Open Access

Targeting Adaptation to Cancer Treatment by Drug Combinations

BioRxiv : the Preprint Server for Biology
H. WangAnil Korkut
April 14, 2021

Gail model utilization in predicting breast cancer risk in Egyptian women: a cross-sectional study.

Breast Cancer Research and Treatment
Basem SalehHadeer Mohamed
April 14, 2021
Open Access

IOERT versus external beam electrons for boost radiotherapy in stage I/II breast cancer: 10-year results of a phase III randomized study.

Breast Cancer Research : BCR
Antonella CiabattoniFelix Sedlmayer
April 14, 2021

LncRNA-miRNA axes in breast cancer: Novel points of interaction for strategic attack.

Cancer Letters
Jaganathan VenkateshPaola Marcato

Sign up to follow this feed and discover related papers.

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Biosensors for Cancer Detection

Biosensors are devices that are designed to detect a specific biological analyte by essentially converting a biological entity (ie, protein, DNA, RNA) into an electrical signal that can be detected and analyzed. The use of biosensors in cancer detection and monitoring holds vast potential. Biosensors can be designed to detect emerging cancer biomarkers and to determine drug effectiveness at various target sites. Biosensor technology has the potential to provide fast and accurate detection, reliable imaging of cancer cells, and monitoring of angiogenesis and cancer metastasis, and the ability to determine the effectiveness of anticancer chemotherapy agents.

Breast Cancer Triple-N

Breast cancer cells have receptors for estrogen, progesterone, HER2 receptors (also called ERBB2). Triple-negative breast cancers do not have any of these receptors. Here are the latest discoveries pertaining to triple-negative breast cancers.

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.

Breast Cancer: Risk Factors

Breast cancer is a multifactorial disease that is influenced by both environmental and genetic factors. Discover the latest research on the environmental and genetic risk factors for breast cancer here.

Breast Cancer: Therapeutic Approaches

Several different therapeutic approaches are used to treat breast cancer. These include chemotherapy, hormonal therapy, targeted therapy, and Immunotherapy. Discover the latest research on breast cancer therapeutic approaches here.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Tumorigenesis

Breast tumorigenesis involves the production or formation of tumor(s) in breast tissue. Discover the latest research on breast tumorigenesis here.

CAR-T cells

Chimeric antigen receptor (CAR) T cells are cells that are genetically engineered to recognize and target specific proteins. The ability of these cells to recognize cancer antigens and eliminate tumor cells have transformed cancer immunotherapy approaches. Here is the latest research on CAR-T cells.

Cancer -Omics

A variety of different high-throughput technologies can be used to identify the complete catalog of changes that characterize the molecular profile of cohorts of tumor samples. Discover the latest insights gained from cancer 'omics' in this feed.

© 2021 Meta ULC. All rights reserved
/feed-previews/breast-cancer-chemo-resistance/82d7d105-0cf8-4832-8e54-dfc4ae3b27fb